|
× |
 |
Longer Time to Antipsychotic Treatment Discontinuation for Any Cause Is Associated With Better Functional Outcomes for Patients With Schizophrenia, Schizophreniform Disorder, or Schizoaffective Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
A High-Density Whole-Genome Association Study Reveals That APOE Is the Major Susceptibility Gene for Sporadic Late-Onset Alzheimer's Disease PDF |
$40.00 |
|
$40.00 |
|
× |
|
Use of Non-Psychiatric Medications With Potential Depressive Symptom Side Effects and Level of Depressive Symptoms in Major Depressive Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Risperidone Liquid Concentrate and Oral Lorazepam Versus Intramuscular Haloperidol and Intramuscular Lorazepam for Treatment of Psychotic Agitation PDF |
$40.00 |
|
$40.00 |
|
× |
|
Cytochrome P450 2D6 Polymorphism and Its Impact on Decision-Making in Psychopharmacotherapy: Finding the Right Way in an Ultrarapid Metabolizing Patient PDF |
$40.00 |
|
$40.00 |
|
× |
|
Safety of Selegiline Transdermal System in Clinical Practice: Analysis of Adverse Events From Postmarketing Exposures PDF |
$40.00 |
|
$40.00 |
|
× |
|
Childhood Abuse and Platelet Tritiated-Paroxetine Binding in Bulimia Nervosa: Implications of Borderline Personality Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Use of Preventive Health Services in People With Serious Mental Illness: Consumer Perspectives on Barriers and Solutions PDF |
$40.00 |
|
$40.00 |
|
× |
|
Efficacy and Safety of Low-Dose Doxepin in Depressed Patients Suffering From Insomnia: A Retrospective, Naturalistic Case Series Analysis PDF |
$40.00 |
|
$40.00 |
|
× |
|
Remission Rates Following Electroconvulsive Therapy and Relation to Index Episode Duration in Patients With Psychotic Versus Nonpsychotic Late-Life Depression PDF |
$40.00 |
|
$40.00 |
|
× |
|
Acute Effects of Parent Stimulant Medication Versus Behavioral Parent Training on Mothers' ADHD, Parenting Behavior, and At-Risk Children PDF |
$40.00 |
|
$40.00 |
|
× |
|
Psychotic Features in Patients With Major Depressive Disorder: A Report From the European Group for the Study of Resistant Depression PDF |
$40.00 |
|
$40.00 |
|
× |
|
The History and Current State of Antidepressant Clinical Trial Design: A Call to Action for Proof-of-Concept Studies PDF |
$40.00 |
|
$40.00 |
|
× |
|
Prognostic Subgroups for Remission, Response, and Treatment Continuation in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Trial PDF |
$40.00 |
|
$40.00 |
|
× |
|
Serotonin-System Polymorphisms (5-HTTLPR and -1438G/A) and Responses of Patients With Bulimic Syndromes to Multimodal Treatments PDF |
$40.00 |
|
$40.00 |
|
× |
|
Longitudinal Trajectories of Psychotic-Like Experiences and Their Relationship to Emergent Mental Disorders Among Adolescents: A 3-Year Cohort Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Meta-Analytic Review of Double-Blind, Placebo-Controlled Trials of Antidepressant Efficacy of Omega-3 Fatty Acids PDF |
$40.00 |
|
$40.00 |
|
× |
|
The Economic Burden of Schizophrenia in the United States in 2002 PDF |
$40.00 |
|
$40.00 |
|
|
